RxDoctor Payments Data

Clinton Baird, MD

Neurological Surgery · Tulsa, OKNPI 1972656908

Payments from drug & device makers

What this record shows

This record is dominated by other: $600,000 of the $621,288 with a category attached, or 96.6%. Omnia Medical, LLC accounts for 99.9% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2021 at $220,559 and has fallen 99.9% since, to $326 in 2025. Among neurological surgery clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$621,288in general payments, 2019–2025

Across 21 payments — averaging $29,585 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Omnia Medical, LLC$621K
  • Johnson & Johnson$171
  • Abbott$141
  • Boston Scientific$129
  • Providence Medical Technology, Inc.$67
  • Zimmer Biomet$59
  • plus $222 from 7 others

What the payments were for

  • Consulting fees$20,5003%
  • Food & beverage$7880%
  • Other$600,00097%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$621,288 in reported general payments places this provider in the 95th percentile of 80 neurological surgery providers in Oklahoma.

See all neurological surgery providers in Oklahoma

Medicare billing

Part B allowed, 2024
$344,854
Medicare patients
524
Services billed
2,909

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen684$21,945
BelbucaBuprenorphine Hcl24$20,997
Buprenorphine65$17,227
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen564$17,037
Xtampza ErOxycodone Myristate31$13,923
Oxycodone Hcl344$6,257
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl21$5,094
Buprenorphine Hcl104$3,987
Morphine Sulfate ErMorphine Sulfate124$3,745
Pregabalin193$3,201
Fentanyl11$1,359
Morphine Sulfate29$1,087
Tramadol Hcl67$683
Ziprasidone Hcl14$603
Hydromorphone Hcl37$570

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →